Patrick Jamieson

VP, Transformations at Ginkgo Bioworks

Patrick Jamieson is the Vice President of Transformations at Ginkgo Bioworks. Prior to this role, they served as the Vice President of Strategy & Corporate Development at Motional from December 2019 to November 2022. Patrick also served as a Board Observer at KRONO-SAFE from October 2019 to March 2020 and Affectiva from January 2019 to March 2020. In addition, Jamieson was the Director of Strategic Investments at Aptiv from April 2018 to December 2019. Patrick began their career at GSK as the Director, Business Development & Licensing from June 2016 to April 2018. Patrick then became the Associate Director, Business Development & Licensing from July 2014 to June 2016. Prior to GSK, Jamieson worked as the Manager, Business Development & Licensing at Novartis Consumer Health from June 2013 to July 2014. Patrick also served as the Segment Finance Manager at Thermo Fisher Scientific from August 2011 to June 2013. Jamieson began their career at Thermo Fisher Scientific as a Finance Associate (Financial Leadership Development Participant) from June 2009 to August 2011.

Patrick Jamieson has a Bachelor of Science in Economics-Finance from Bentley University, a Negotiation for Executives certificate from MIT Sloan Executive Education, and a Bachelor of Science in Economics-Finance from Copenhagen Business School.

Links

Previous companies

Aptiv logo
Thermo Fisher Scientific logo
Novartis logo
Krono-Safe logo
otonomo logo

Timeline

  • VP, Transformations

    November, 2022 - present

View in org chart